Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” first quarter 2025 investor letter. A copy of the letter can be downloaded here. 2025 got ...

While we may not be providing direct patient care, or interacting with customers one-on-one, our Distribution Center is ...

The U.S. Food and Drug Administration issued letters to several companies -- including major pharmacy chains -- this week, warning them against manufacturing or selling unapproved eye products.

The FDA said the products are illegally marketed to treat certain conditions. The U.S. Food and Drug Administration issued letters to several companies -- including major pharmacy chains -- this week, ...

The US Food and Drug Administration on Monday sent warning letters to CVS, Walgreens and other companies over manufacturing and marketing of unapproved eye products the agency says could pose a risk ...